A small molecule that binds to a receptor found on muscle cells speeds up energy metabolism--but only in female mice. In an article published online on March 5 in Chemistry & Biology, researchers show that female mice treated with a molecule found in tree leaves could indulge in high-fat foods without gaining weight or accumulating fat. Males did not enjoy similar benefits, highlighting the need to study both sexes while developing drugs for obesity and other conditions.
"An equivalent diet pill in humans would allow people to maintain a healthy weight, despite a high-fat diet," says senior author Dr. Keqiang Ye, of the Emory University School of Medicine in Atlanta. "The pill would burn calories without affecting appetite."
Research has shown that a hormone called brain-derived neurotrophic factor (BDNF), which is secreted after physical exercise, controls body weight gain by eliciting signals to suppress food intake and enhance energy expenditure. Manipulation of this signaling represents a promising strategy for combating obesity; however, BDNF degrades quickly in the body.
While developing a drug for neurological diseases, Dr. Ye and his colleagues discovered that a small natural product called 7,8-dihydroxyflavone (7,8-DHF) that is found in Godmania aesculifolia and primula tree leaves from Central and South America mimics the physiological functions of BDNF. The molecule seems to work by interfering with enzymes that acts as the body's fuel gauge.
When mice were fed 7,8-DHF along with a high-fat diet, females maintained their appetite but kept a healthy weight and metabolic profile without demonstrable side effects; males, on the other hand, still developed obesity and diabetes. The mechanisms behind this sex difference are unknown, but sex-specific hormones might play a role. For example, estrogen has been proposed to enhance the effects of BDNF signaling, and 7,8-DHF was reported to alter estrogen metabolism.
Dr. Ye's team has designed a biological agent that helps 7,8-DHF be absorbed by the body. It is now heading for phase I human clinical trials in China and Australia treating various BDNF-implicated neurological diseases--including Alzheimer's--as well as obesity and diabetes.
"This drug has been extensively tested in a variety of neurological diseases in both male and female animal models and exhibits very promising therapeutic efficacy, suggesting that this drug is efficacious for both sexes in the central nervous system," Ye said. "Clearly, further investigation is necessary to explore why it selectively burns the fat for the female mice."
Materials provided by Cell Press. Note: Content may be edited for style and length.
Cite This Page: